Bioactive 2-benzazepines were accessed in an atom- and step-economical manner by a versatile palladium-catalyzed C-H activation strategy. The C-H arylation featured low catalyst loading and a mild base being reflected by ample scope and high functional group tolerance. Thereby, the benzotriazolodiazepinones were identified as novel HSP90 inhibitor lead compounds, with considerable potential for anti-cancer applications.
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H activation: Identification of a Unique HSP90 Inhibitor Scaffold
Giuseppe Zanoni;VIRELLI, MATTEO;Giorgio Colombo;Alessio Porta
2018-01-01
Abstract
Bioactive 2-benzazepines were accessed in an atom- and step-economical manner by a versatile palladium-catalyzed C-H activation strategy. The C-H arylation featured low catalyst loading and a mild base being reflected by ample scope and high functional group tolerance. Thereby, the benzotriazolodiazepinones were identified as novel HSP90 inhibitor lead compounds, with considerable potential for anti-cancer applications.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
